160 related articles for article (PubMed ID: 11559810)
1. Multiple effector functions mediated by human immunodeficiency virus-specific CD4(+) T-cell clones.
Norris PJ; Sumaroka M; Brander C; Moffett HF; Boswell SL; Nguyen T; Sykulev Y; Walker BD; Rosenberg ES
J Virol; 2001 Oct; 75(20):9771-9. PubMed ID: 11559810
[TBL] [Abstract][Full Text] [Related]
2. Fine specificity and cross-clade reactivity of HIV type 1 Gag-specific CD4+ T cells.
Norris PJ; Moffett HF; Brander C; Allen TM; O'Sullivan KM; Cosimi LA; Kaufmann DE; Walker BD; Rosenberg ES
AIDS Res Hum Retroviruses; 2004 Mar; 20(3):315-25. PubMed ID: 15117455
[TBL] [Abstract][Full Text] [Related]
3. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
[TBL] [Abstract][Full Text] [Related]
4. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
[TBL] [Abstract][Full Text] [Related]
5. Diverse repertoire of HIV-1 p24-specific, IFN-gamma-producing CD4+ T cell clones following immune reconstitution on highly active antiretroviral therapy.
Boritz E; Palmer BE; Livingston B; Sette A; Wilson CC
J Immunol; 2003 Jan; 170(2):1106-16. PubMed ID: 12517980
[TBL] [Abstract][Full Text] [Related]
6. HIV p24-specific helper T cell clones from immunized primates recognize highly conserved regions of HIV-1.
Mills KH; Kitchin PA; Mahon BP; Barnard AL; Adams SE; Kingsman SM; Kingsman AJ
J Immunol; 1990 Mar; 144(5):1677-83. PubMed ID: 1689753
[TBL] [Abstract][Full Text] [Related]
7. CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjects.
Boaz MJ; Waters A; Murad S; Easterbrook PJ; D'Sousa E; van Wheeley C; Vyakarnam A
Clin Exp Immunol; 2003 Dec; 134(3):454-63. PubMed ID: 14632751
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunization.
Venturini S; Mosier DE; Burton DR; Poignard P
J Virol; 2002 Jul; 76(14):6987-99. PubMed ID: 12072499
[TBL] [Abstract][Full Text] [Related]
9. Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection.
Malhotra U; Holte S; Zhu T; Delpit E; Huntsberry C; Sette A; Shankarappa R; Maenza J; Corey L; McElrath MJ
J Virol; 2003 Feb; 77(4):2663-74. PubMed ID: 12552005
[TBL] [Abstract][Full Text] [Related]
10. Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes.
Wilson CC; Palmer B; Southwood S; Sidney J; Higashimoto Y; Appella E; Chesnut R; Sette A; Livingston BD
J Virol; 2001 May; 75(9):4195-207. PubMed ID: 11287569
[TBL] [Abstract][Full Text] [Related]
11. Th1 cells specific for HIV-1 gag p24 are less efficient than Th0 cells in supporting HIV replication, and inhibit virus replication in Th0 cells.
Vyakarnam A; Matear PM; Martin SJ; Wagstaff M
Immunology; 1995 Sep; 86(1):85-96. PubMed ID: 7590887
[TBL] [Abstract][Full Text] [Related]
12. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms.
Lewinsohn DM; Bement TT; Xu J; Lynch DH; Grabstein KH; Reed SG; Alderson MR
J Immunol; 1998 Mar; 160(5):2374-9. PubMed ID: 9498779
[TBL] [Abstract][Full Text] [Related]
13. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
[TBL] [Abstract][Full Text] [Related]
14. Characterization of effector functions of human peptide-specific CD4+ T-cell clones for an intracellular pathogen.
Klucar P; Barnes PF; Kong Y; Samten B; Tvinnereim A; Spallek R; Nepom GT; Singh M; Shams H
Hum Immunol; 2008 Aug; 69(8):475-83. PubMed ID: 18588932
[TBL] [Abstract][Full Text] [Related]
15. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.
Rosenberg ES; Billingsley JM; Caliendo AM; Boswell SL; Sax PE; Kalams SA; Walker BD
Science; 1997 Nov; 278(5342):1447-50. PubMed ID: 9367954
[TBL] [Abstract][Full Text] [Related]
16. Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal.
Zheng NN; Kiviat NB; Sow PS; Hawes SE; Wilson A; Diallo-Agne H; Critchlow CW; Gottlieb GS; Musey L; McElrath MJ
J Virol; 2004 Dec; 78(24):13934-42. PubMed ID: 15564501
[TBL] [Abstract][Full Text] [Related]
17. A chain section containing epitopes for cytotoxic T, B and helper T cells within a highly conserved region found in the human immunodeficiency virus type 1 Gag protein.
Nakamura Y; Kameoka M; Tobiume M; Kaya M; Ohki K; Yamada T; Ikuta K
Vaccine; 1997 Apr; 15(5):489-96. PubMed ID: 9160516
[TBL] [Abstract][Full Text] [Related]
18. CD4+ T cell targeting of human immunodeficiency virus type 1 (HIV-1) peptide sequences present in vivo during chronic, progressive HIV-1 disease.
Boritz E; Rapaport EL; Campbell TB; Koeppe JR; Wilson CC
Virology; 2007 Apr; 361(1):34-44. PubMed ID: 17169395
[TBL] [Abstract][Full Text] [Related]
19. Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years.
Lind A; Sommerfelt M; Holmberg JO; Baksaas I; Sørensen B; Kvale D
Scand J Infect Dis; 2012 Aug; 44(8):566-72. PubMed ID: 22339485
[TBL] [Abstract][Full Text] [Related]
20. Conserved HIV-1 Gag p24 Epitopes Elicit Cellular Immune Responses That Impact Disease Outcome.
Tarosso LF; Vieira VA; Sauer MM; Tomiyama HI; Kalil J; Kallas EG
AIDS Res Hum Retroviruses; 2017 Aug; 33(8):832-842. PubMed ID: 28594230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
